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Abstract 
Following exposure to DNA damaging agents that block the progress of the 
replication fork, mono-ubiquitination of PCNA mediates the switch from replicative 
to translesion synthesis DNA polymerases.  We show that in human cells, PCNA is 
mono-ubiquitinated in response to methyl methanesulfonate and mitomycin C, as well 
as UV light, albeit with different kinetics, but not in response to bleomycin or 
camptothecin. Cyclobutane pyrimidine dimers are responsible for most of the PCNA 
ubiquitination events following UV-irradiation. Failure to ubiquitinate PCNA results 
in substantial sensitivity to UV and MMS, but not to camptothecin or bleomycin. 
PCNA ubiquitination is dependent on RPA, but independent of ATR-mediated 
checkpoint activation. After UV-irradiation, there is a temporal correlation between 
the disappearance of the de-ubiquitinating enzyme USP1 and the presence of PCNA 
ubiquitination, but this correlation was not found after chemical mutagen treatment. 
Using cells expressing photolyases, we are able to remove the UV lesions and we 
show that PCNA ubiquitination persists for many hours after the damage has been 
removed. We present a model of translesion synthesis behind the replication fork to 
explain the persistence of ubiquitinated PCNA. 
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Introduction 
The replication of damaged DNA is a topic of much current interest following the 
discovery of the specialised Y-family of DNA polymerases, which are able to bypass 
lesions in DNA. There are four Y-family members in mammalian cells, DNA 
polymerase (pol) η, polι, polκ and Rev1, each with a different substrate specificity (1-
3).  
 
Genetic studies using Saccharomyces cerevisiae have implicated ubiquitin-
conjugating systems in the replication of damaged DNA, and the ubiquitination target 
is the DNA polymerase sliding clamp accessory protein, PCNA (4). In response to 
DNA damage, Rad6 and Rad18 mediate the mono-ubiquitination of PCNA on lysine-
164, and subsequent poly-ubiquitination is brought about by Ubc13-Mms2 and Rad5. 
Mono-ubiquitination appears to trigger translesion synthesis (TLS) to bypass DNA 
lesions, whereas polyubiquitination channels the damage into a poorly understood 
error-free damage-avoidance mechanism (4, 5).  
 
In human fibroblasts, mono-ubiquitination on lysine-164 is by far the major 
modification of PCNA and is easily detectable on exposure of replicating cells to 
DNA damage induced by ultraviolet light (UV) or to replication arrest by 
hydroxyurea (HU) (6). Polyubiquitination has recently been detected at much lower 
levels (7, 8). Monoubiquitination of PCNA increases its affinity for polη, polι and 
Rev1 (6, 9-12). The increased affinity of mono-ubiquitinated PCNA (Ub-PCNA) for 
Y-family polymerases is mediated by ubiquitin-binding domains that have been 
identified in all the Y-family polymerases (10-13), and provides a mechanism for 
bringing about the polymerase switch, whereby the blocked replicative DNA 
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polymerase is replaced by a TLS polymerase that can bypass the blocking lesion (1). 
Ubiquitinated PCNA activates the in vitro damage-bypass activities of polη and Rev1 
(14). 
 
Whereas ubiquitination of PCNA is brought about by the Rad6-Rad18 system, it is 
kept in check in human cells by the de-ubiquitinating enzyme (DUB) USP1 (15). 
Following high doses of UV, USP1 disappears from the cell (15, 16). 
 
In this paper we examine the response of PCNA ubiquitination to different DNA 
damaging agents in human cells, we show that mutation of PCNA-K164 confers UV 
and MMS sensitivity to the cells, we demonstrate that PCNA ubiquitination and 
activation of cell cycle checkpoints are independent events and we show that PCNA 
ubiquitination persists even after removal of the lesions. 
 
Results 
PCNA ubiquitination following exposure to different damaging treatments. 
We previously showed that PCNA was monoubiquitinated in response to UV-
irradiation or treatment with HU, but not with ionising radiation (6). In our earlier 
work, PCNA ubiquitination remained elevated for at least 24 h after UV-irradiation, 
and our data shown in Figure 1A and B (upper panels) indicate that this elevated level 
persisted in MRC5V1 cells for more than 48 h after UV doses of 10 and 20 Jm-2. In 
all experiments shown, we loaded the same proportion of the total cell population in 
each lane. Thus the intensity of the band corresponding to Ub-PCNA represents the 
absolute level of ubiquitinated PCNA in the culture rather than the amount relative to 
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unmodified PCNA or per μg protein. We have analysed the data in this way to avoid 
any apparent loss of PCNA ubiquitination by dilution when cells divide. 
 
UV-irradiation generates two major photoproducts in DNA, cyclobutane pyrimidine 
dimers (CPD) and 6-4 photoproducts (6-4PP). To determine which of these lesions is 
responsible for the ubiquitination of PCNA, we used XP-A cells which express 
photolyases specific for CPD, 6-4PP or both (17). When UV-irradiated cells are 
exposed to visible light immediately after UV-irradiation, the photolyases reverse the 
cognate photoproducts in situ. More than 90% of the lesions disappear from the DNA 
on exposure to visible light for 90-120 min (Fig S6). Removal of just the CPDs results 
in a significant reduction of PCNA ubiquitination (Fig 1C, compare lanes 3 and 4). In 
contrast removal of 6-4PP has a barely detectable effect (lanes 7, 8), but this might be 
expected as 6-4PP form only 20-30% of total photoproducts. Removal of both 
photolesions prevents the ubiquitination completely (lanes 11 and 12). We conclude 
that both photoproducts are able to elicit ubiquitination of PCNA. 
 
In an attempt to understand the triggering structure(s) for PCNA mono-ubiquitination, 
we have exposed cells to different agents and measured PCNA ubiquitination for 
extended periods of time after damaging treatments. The monofunctional methylating 
agent, methyl methanesulfonate (MMS) generates mainly 7-methylguanine and 3-
methyladenine in DNA together with a small amount of O-6-methylguanine (18). 
Figure 1D (upper panel) shows that Ub-PCNA was detectable 3 h after a one-hour 
MMS treatment and increased in intensity at 24 h and later times. With the 
crosslinking agent mitomycin C, little Ub-PCNA was detectable in the first few hours 
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after treatment, but as with MMS treatment, a strong band appeared at 24 h and 
increased in intensity up to 48 h (Fig 1E, upper panel). 
 
In contrast to these agents, which generate chemical alterations in DNA, bleomycin, 
like ionising radiation, produces double-strand breaks. With this agent, minimal Ub-
PCNA was detected up to 48 h after treatment (Figure S7A). Similar results were 
obtained with camptothecin, an inhibitor of topoisomerase I that generates double-
strand breaks in DNA during DNA replication (data not shown). No PCNA 
ubiquitination was detected following treatment with the microtubule spindle poison 
nocodazole (not shown), confirming that agents that disrupt cell cycle progression 
without affecting DNA replication do not induce the ubiquitination of PCNA. 
 
Failure to ubiquitinate PCNA confers UV and MMS sensitivity 
We have used SV40-transformed MRC5V1 human fibroblasts to generate cell lines 
expressing His-tagged PCNA, either wild-type or mutated at lysine-164, at levels 
similar to those of endogenous PCNA (Figure 2A, lanes 1 and 3). The cDNA for the 
exogenous PCNA contained silent mutations to make it refractory to targeting by 
siRNA directed against endogenous PCNA. Using siRNA, we were able to deplete the 
endogenous PCNA such that more than 80% of the PCNA is expressed from the 
transfected cDNA (Figure 2A, lanes 2 and 4).  The transfected wild-type his-PCNA is 
ubiquitinated following UV-irradiation (Fig 2B, lane 2), whereas the K164R mutant 
his-PCNA is not (Fig 2B, lane 4). Depletion of the endogenous PCNA results in a 
substantial sensitisation of cells expressing mutant PCNA to UV-irradiation (Fig 2C, 
KR) compared to those expressing wild-type PCNA (Fig 2C, WT). Additional 
depletion of polη in cells expressing wild-type PCNA results in only a modest 
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decrease in survival after UV-irradiation (Fig 2C, WT-h) and in cells expressing 
mutant PCNA there is no further decrease in survival (Fig 2C, KR-h). These data 
demonstrate the importance of PCNA ubiquitination for cell survival after UV 
irradiation. 
 
The cells expressing only PCNA-K164R are also sensitive to MMS (Fig 2D), but not 
to camptothecin (Fig 2E) or bleomycin (Fig S7B), consistent with the patterns of 
ubiquitination of PCNA (Fig 1). 
 
PCNA ubiquitination and cell cycle checkpoints 
The spectrum of damaging agents giving rise to PCNA ubiquitination, its dependence 
on Rad18 and the single-stranded DNA-binding properties of Rad18 lead to the 
hypothesis that single-stranded DNA exposed at the site of stalled forks can trigger 
Rad18-mediated ubiquitination of PCNA. Single-stranded regions are also the trigger 
for cell-cycle checkpoints mediated by the ATR protein kinase. To trigger the 
checkpoint, single-stranded DNA needs to be coated with the single-strand DNA 
binding protein, RPA (19). We depleted cells of RPA using the same conditions as 
Zou and Elledge (19). In our initial experiments, we obtained substantial depletion of 
RPA without affecting the ubiquitination of PCNA following UV treatment (data not 
shown). However, when we altered our transfection conditions, we were able to 
reduce RPA to levels that were undetectable on Western blotting (Figure 3A, panel a). 
Under these conditions phosphorylation of Chk1 was reduced as described previously 
(19) (Figure 3A, panel b) and we found that Ub-PCNA formation was also reduced 
substantially (Figure 3A, panel c). We were concerned that depletion of RPA might 
deplete the S phase population of the cells, and that the decreased ubiquitination of 
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PCNA might be a secondary consequence of a lack of S phase cells. We therefore 
analysed the cell cycle status of the RPA- depleted population. Flow cytometry 
showed that the cell cycle distribution of cells depeleted of RPA was very similar to 
that of undepleted cells (Table S1), suggesting that, although undetectable by 
immunoblotting, residual RPA is sufficient to permit DNA replication to continue. 
Our data suggest, therefore, that ubiquitination of PCNA is dependent on RPA.  
 
To examine if Ub-PCNA formation depends on checkpoint activation, we depleted 
MRC5V1 cells of ATR using siRNA. (Figure 3B, panel a). This prevented the UV-
induced phosphorylation of Chk1 (Fig 3B, panel b), demonstrating that checkpoint 
activation had been abrogated. However, 6 h after exposure to 20 Jm-2 UV-irradiation, 
depletion of ATR had no effect on the levels of Ub-PCNA (Figure 3B, panel c). We 
also showed that the ubiquitination of PCNA in cells from a normal individual and 
from a child with Seckel Syndrome caused by a mutation in the ATR gene and 
deficient in ATR signalling (20), were very similar (Figure 3C). We conclude that 
ubiquitination of PCNA is not dependent on a checkpoint response mediated by ATR.  
 
Persistence of Ub-PCNA after removal of the damage. 
The results of Figure 1 demonstrate that Ub-PCNA persists for a long time after 
formation of the DNA damage. However many types of damage are known to persist 
for long periods, and the apparent persistence of Ub-PCNA may represent a dynamic 
equilibrium between cycles of ubiquitination and de-ubiquitination as the replication 
machinery encounters successive lesions. To test if this is the case, we again used the 
XP-A cells that express both photolyases (17). These cells were UV-irradiated (20 Jm-
2) and then incubated for 6 h in the dark to permit replication forks to stall at damaged 
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sites and Ub-PCNA to accumulate. The cells were then exposed to visible light for 
two hours. Samples were taken at various times after photoreactivation and analysed 
for Ub-PCNA. Figure 4A (odd lanes) shows that despite the removal of nearly all the 
damage, Ub-PCNA persisted for many hours. We obtained similar results after a 
lower dose of 5 Jm-2 (not shown). We considered the possibility that, after the damage 
has been removed, the Ub-PCNA is released from the chromatin into the PCNA pool. 
In the photoreactivated cells, however, although much of the unmodified PCNA was 
extracted by triton, most of the Ub-PCNA was refractory to triton extraction (Figure 
4A, compare even with odd lanes), indicating that it remained associated with 
chromatin for many hours after removal of the damage. 
 
Recently USP1 was identified as a DUB that de-ubiquitinates Ub-PCNA. Following 
high doses of UV-irradiation, USP1 was cleaved and this permitted Ub-PCNA to 
accumulate (15). These data suggested that USP1 might regulate the level of PCNA 
ubiquitination. Given the existence of a DUB for Ub-PCNA, it seemed curious that 
Ub-PCNA persisted in our experiments. We therefore measured the level of USP1 
and Ub-PCNA in the same cell pellet under different conditions. In agreement with 
the report of Huang et al (15), we observed that USP1 disappeared from cell extracts 
after UV-irradiation of the cells. We found that this occurred even after relatively low 
UV doses (Figure 1A, B, lower panels). There was an approximately 70% reduction 8 
h after 10 Jm-2 and recovery at 72 h, whereas, after 20 Jm-2, as might be expected, the 
response was more severe. USP1 became barely detectable after 8 h and did not 
recover within the time of the experiment. After both doses, the ubiquitination of 
PCNA (upper panels) correlated well with the disappearance of USP1. Furthermore in 
the photolyase experiments described above, we found that USP1 remained at 
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undetectable levels for at least 24 hours after reversal of the damage by 
photoreactivation (Figure 4B, top panel). The levels of USP1 in these experiments 
therefore show a good inverse correlation with those of Ub-PCNA, consistent with the 
idea that USP1 is an important regulator of Ub-PCNA (15).  
 
We also measured USP1 levels following treatments with MMS and MMC. In 
striking contrast to the results with UV-irradiation, we were unable to detect any 
significant loss of USP1 after treatment with these chemicals (Figs 1D and E, lower 
panels). Indeed there was an increase in USP1 at later times, more or less concomitant 
with the increase in PCNA ubiquitination. 
 
Discussion 
Ubiquitination of PCNA is a central control point for mediating the replication of 
damaged DNA, but many questions remain concerning the ubiquitination process. 
What is the trigger that turns it on and what is the mechanism for turning it off? We 
and others have shown that PCNA is efficiently ubiquitinated following exposure to 
UV, MMS, MMC and HU, but not by ionising radiation, bleomycin or camptothecin 
(this paper and (21)) nor by daunomycin, actinomycin D and neocarzinostatin (22). 
The former agents all cause stalling of the replication fork. A likely result of fork 
stalling is either the dissociation of the replicative helicase from the stalled replication 
machinery and exposure of single-stranded DNA ahead of the replication fork, or 
uncoupling of the synthesis on leading and lagging strands, exposing single-stranded 
regions on the leading strand (23). This single-stranded DNA likely binds Rad18, 
which together with either or both of the Rad6 orthologs carries out the ubiquitination 
process (24, 25). Ionising radiation, bleomycin, neocarzinostatin and camptothecin 
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generate double strand breaks either directly or during replication and would not 
therefore be expected to generate regions of single-stranded DNA at the forks. MMC 
produces interstrand DNA crosslinks. These will result in stalling of the fork, but the 
cross-links are likely to provide physical barriers to unwinding of the DNA ahead of 
the stalled forks. This may account for the lack of ubiquitination of PCNA at early 
times after treatment. The accumulation of Ub-PCNA at much later times is likely to 
be a result of secondary processes involved in the repair of the cross-links.  
 
When we replaced PCNA with the K164R mutant form that cannot be ubiquitinated, 
the viability of the cells was unaffected. Consistent with this observation, Langerak et 
al recently generated a knock-in PCNA-K164R mouse, which was viable (26). These 
mice were infertile and had an altered somatic hypermutation spectrum, but were 
otherwise healthy. As in budding and fission yeasts (4, 27) and DT40 chicken cells 
(28), therefore, the inability to ubiquitinate PCNA is compatible with life in mammals. 
When treated with PCNA-specific siRNA, our “K164R cells” are, like DT40 cells 
expressing human PCNA-K164R as the sole source of PCNA (28), sensitive to UV-
irradiation. At first sight this may appear not unexpected. However, in response to UV, 
Ub-PCNA has been hypothesized to facilitate the switch from replicative to TLS 
polymerase to enable TLS past UV lesions (6). Interestingly, cells in which polη is 
depleted (Figure 2C), like XP variant cells defective in polη (29), are barely sensitive 
to killing by UV light. The PCNA-K164R cells, in contrast, show much more 
pronounced UV sensitivity. This suggests that modification of PCNA has roles other 
than recruitment of polη in response to UV-irradiation. These roles could include 
recruitment of other polymerases involved in TLS past 6-4 photoproducts. For 
example, Rev1 also binds to ubiquitinated PCNA (12) as well as to other Y-family 
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polymerases and to polζ, suggesting that it might act as a platform for recruiting other 
polymerases (30, 31). In addition polyubiquitination of PCNA might facilitate an 
error-free recombination-mediated process for bypassing lesions, as found in yeast (4, 
5). A further possibility is that ubiquitination of PCNA has a role outside of S phase. 
We have shown in S pombe that PCNA is ubiquitinated in G2 cells in response to 
DNA damage (27), and work by N Zlatanou and PLK, to be published elsewhere, has 
revealed that PCNA is ubiquitinated in response to DNA damage in quiescent human 
fibroblasts.  The PCNA-K164R cells are also sensitive to MMS, implying an 
important role for ubiquitinated PCNA in recovery from MMS-induced damage. 
Further studies will be required to determine if this role involves TLS, recombination, 
or both.   
 
Stalling of the replication fork also activates ATR-mediated cell cycle checkpoints 
and mono-ubiquitination of FANCD2 (32). This raises the question as to whether 
these processes are co-ordinated and interdependent. We found that depletion of RPA 
resulted in a reduction in PCNA ubiquitination, in agreement with findings of Bi et al 
(33), and with recent observations in S. cerevisiae (34). However, we found that 
reduced levels of ATR had little effect on PCNA ubiquitination. These results are 
somewhat at variance with those of Bi et al, who reported some reduction of 
ubiquitination in ATR deficient cells (33), but agree with a recent report showing no 
effect of reduction of ATR (35). They are also consistent with our earlier findings in S. 
pombe, in which deletion of the checkpoint kinase genes rad3 and tel1 (ATR and 
ATM orthologs) had no effect on PCNA ubiquitination (27) and with similar results 
in S. cerevisiae (34) and Xenopus laevis (24). We envisage therefore that PCNA 
ubiquitination and checkpoint activation are independently and automatically 
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triggered by a “state of emergency” indicated by exposed single stranded DNA at the 
replication fork.  
 
Ubiquitination of PCNA is also regulated by the DUB USP1, which is able to remove 
ubiquitin from Ub-PCNA (15). This is at first sight difficult to reconcile with our 
finding that Ub-PCNA persisted for many hours even after replication blocks were 
removed. However, we have extended the original observations of Huang et al (15) to 
demonstrate that, after UV-irradiation of MRC5V1 cells, USP1 disappears and is 
barely detectable during the periods when PCNA ubiquitination persists, even when 
the damage has been removed.  In contrast, ubiquitination of PCNA following MMS 
or MMC treatment was not accompanied by a loss of USP1. This suggests that USP1 
is an important regulator of PCNA ubiquitination in response to UV, whereas after 
chemical treatments, the ubiquitinated PCNA is refractory to USP1. One possible 
explanation is that USP1 is sequestered away from the Ub-PCNA. Alternatively, 
USP1 is itself regulated and activated by association with a partner protein, UAF1 
(16), and this activation might be differentially affected by different DNA damaging 
treatments. 
 
What is the explanation for the persistence of Ub-PCNA following UV-irradiation, 
even after UV damage has been removed? In E. coli, DNA synthesised in UV-
irradiated cells contains gaps opposite UV lesions and these gaps are subsequently 
sealed (36). This led to a model in which the gaps were sealed behind the replication 
fork so that the bypass past the lesion was independent of replication fork progression. 
More recent models have however assumed that TLS occurs at the stalled forks and 
that fork progression and TLS are co-ordinated. This may not be the case and recent 
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work in yeast has provided direct support for the older model of gaps behind the 
replication fork (23). Furthermore Heller and Marians have shown, using a bacterial 
in vitro system, that replication can restart downstream of a replication block, even on 
the leading strand (37). In addition, Waters and Walker found high levels of the Y-
family polymerase Rev1 in G2 cells in yeast and inferred that this was an indication 
of a postreplicative gap-filling step (38). We develop this model to explain the 
persistence of Ub-PCNA in UV-irradiated cells (Figure 5). We propose that when the 
replication fork stalls at a lesion, PCNA becomes ubiquitinated (Figure 5A) and 
shortly afterwards a new replication apparatus is assembled beyond the lesion, with a 
new molecule of PCNA (Figure 5B). Synthesis continues up to the next lesion, where 
another Ub-PCNA molecule is deposited and replication restarts again beyond the 
lesion (Figure 5C). At some later time, the gaps are sealed by polη and/or maybe 
other Y-family polymerases, depending on the nature of the lesion (Figure 5D), and 
the ubiquitinated PCNA is left on the DNA, perhaps because there are no RFC 
molecules in the vicinity to unload it. The net result is that Ub-PCNA molecules 
remain on the DNA until they are disassembled at the next round of replication or, at 
least in the case of UV damage, de-ubiquitinated when USP1 levels are restored. 
Figure 5 displays the proposed situation on the leading strand, but a similar process 
could occur on the lagging strand. 
 
Might the persistence of Ub-PCNA after the damage has been removed, together with 
its affinity for error-prone Y-family polymerases, result in inappropriate recruitment 
of these polymerases to the replication fork and an elevated mutation rate? This is 
unlikely for two reasons. First, if the model proposed above is correct, the Ub-PCNA 
remaining on the chromatin will be behind the replication fork on DNA that has 
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already been replicated, and will therefore be harmless. Second, the replicative 
polymerases are much more efficient and processive than the Y-family members. 
Once the replicative polymerase is engaged and replicating an undamaged stretch of 
DNA, it is unlikely that a relatively inefficient Y-family polymerase will be able to 
compete effectively (39). It is only when passage of the replication fork is blocked 
and the replicative polymerases cannot proceed, that engagement of the Y-family 
polymerases becomes an issue. 
 
Is the above model of TLS behind the forks compatible with the findings in several 
reports that pol η and ι and Rev1 are localised in replication foci (40-42)? There is a 
widely held misconception that forks and foci are one and the same entity. In fact, 
foci are quite large structures that are thought to contain 5-20 replication forks. It is 
therefore perfectly plausible that the gapped structure, though behind the fork, 
remains associated with the focus. 
 
Materials and Methods 
SV40-transformed human fibroblast line MRC5V1, grown in Eagle’s MEM with 10% 
or 15% fetal calf serum, was used in most experiments. For generation of cells 
expressing exogenous PCNA, His-PCNA constructs were used that contained 
mutations rendering them refractory to siRNA knock-down. Transfection and siRNA 
treatment used standard procedures. For photoreactivation, XP-A cells expressing 
photolyases were exposed to visible light at different times following UVC irradiation. 
Further details of Materials and Methods are presented as supplementary information. 
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Figure legends 
Figure 1 PCNA ubiquitination after DNA damaging agents. 
MRC5V1 cells were UV-irradiated with (A) 10 or (B) 20 Jm-2, incubated for the 
indicated times and analysed by immunoblotting with anti-PCNA (upper panels) or 
anti-USP1 antibody (lower panels). - UV, mock-treated cells incubated for 6h; (C) 
XP-A cells expressing the indicated photolyase were UV-irradiated (10 Jm-2), 
exposed or not to photoreactivating light for 2 h (PR), incubated for a further 6 h and 
analysed as in (A). Cells were treated with (D) 1 mM MMS for 1h, (E)  8 μg/ml 
mitomycin C for 30 min, followed by incubation for the indicated times prior to 
harvesting and analysis by immunoblotting.  
 
Figure 2 UV sensitivity of cells expressing PCNA-K164R 
A, MRC5V1 cell clones expressing his-tagged wild-type PCNA or PCNA-K164R 
were either mock-transfected or treated with PCNA-specific siRNA and PCNA levels 
measured after 72h; B, After transfection with PCNA siRNA, the cells were UV-
irradiated (20 Jm-2), incubated for 5 h and analysed for PCNA ubiquitination. C, D, E: 
UV, MMS, and camptothecin survival curves of cells depleted for endogenous PCNA 
and expressing wild-type (WT) or mutant (KR) his-PCNA. Where indicated (-h), cells 
were also depleted for polη. Error bars: SEM of 3-4 experiments. 
 
Figure 3 PCNA ubiquitination in RPA or ATR knock down cells 
A, MRC5V1 cells were transfected with RPA70 siRNA. After 72h incubation, cells 
were either irradiated or not with 10 Jm-2 UV and incubated for 0.5 or 6 h. Cell 
extracts were analysed by immunoblotting with (top to bottom) anti-RPA70, anti-
Chk1-P-Ser317, PC10 and anti-vimentin (loading control) antibody. Lanes 1, 3, 5; 
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non-targeting siRNA control. Lanes 2, 4, 6; RPA siRNA transfected samples. B, 
MRC5V1 cells were transfected with non-targeting or ATR siRNA, UV irradiated (20 
Jm-2) 72 h later, incubated for 6 h and analysed as in A. C, Normal or Seckel 
Syndrome lymphoblastoid cells were UV-irradiated with the indicated doses and 
incubated for 6 h prior to lysis and analysis. 
 
Figure 4 Persistence of PCNA ubiquitination 
PH-XPA cells were irradiated with 20 Jm-2 UV, incubated for 6h, and then 
photoreactivated for 2h. After further incubation for the indicated times, PCNA in cell 
lysates was detected by immunoblotting. In A, duplicate samples were analysed either 
with or without prior extraction with triton, as indicated. In B, lysates were analysed 
for both USP1 and PCNA ubiquitination. 
 
Figure 5 Model for persistence of Ub-PCNA 
(A) On blocking of the replication fork at a lesion (X), PCNA becomes ubiquitinated 
(U) (Note that only one ubiquitin molecule is shown for simplicity, but it is likely that 
all three monomers of the homotrimeric ring become ubiquitinated). (B) A new 
replication apparatus is assembled beyond the lesion, leaving a gap. (C) The process 
is repeated at the next lesion. (D) Some time later the gap opposite the first lesion is 
filled, as indicated by the thick line. 
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